The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Genital erosive lichen planus (GELP) is a chronic inflammatory disease causing painful
genital sores and scarring in women. Treatment options are limited and often unsatisfactory.
This trial will study the effects of treatment with apremilast and quality of life and sexual
function in women with GELP.